01 55GLAXO GRP LTD
02 52GLAXOSMITHKLINE
03 3HALEON US HOLDINGS
01 311116721*PED
02 137439393
03 57439393*PED
04 27488827
05 27498440
06 18062264
07 18147461
08 58161968
09 58161968*PED
10 38183257
11 38201556
12 28309572
13 18347879
14 88511304
15 58511304*PED
16 58534281
17 58534281*PED
18 88746242
19 88746242*PED
20 89333310
21 89333310*PED
22 29750726
23 111090294
24 611116721
01 17Y
02 93Blank
01 65Y
02 45Blank
01 42025-04-27
02 132025-05-21
03 32025-07-27
04 52025-11-21
05 12026-04-05
06 82027-06-14
07 82027-10-02
08 52027-12-14
09 22027-12-18
10 52028-02-05
11 82028-04-02
12 12028-07-15
13 52028-08-05
14 12028-10-15
15 32029-02-05
16 62029-02-26
17 32029-08-26
18 52030-03-08
19 52030-09-08
20 82030-10-11
21 32030-11-29
22 82031-04-11
Patent Expiration Date : 2027-06-14
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 8511304
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-1691
Delist Requested :
Patent Use Description : INDICATED FOR THE ONCE...
Patent Expiration Date : 2027-06-14
Patent Expiration Date : 2025-04-27
FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 8309572
Drug Substance Claim :
Drug Product Claim :
Application Number : 209482
Patent Use Code : U-2129
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-04-27
Patent Expiration Date : 2025-05-21
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 7439393
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-2099
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-05-21
Patent Expiration Date : 2027-06-14
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 8511304
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-1424
Delist Requested :
Patent Use Description : LONG-TERM, ONCE DAILY ...
Patent Expiration Date : 2027-06-14
Patent Expiration Date : 2025-05-21
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 7439393
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-1691
Delist Requested :
Patent Use Description : INDICATED FOR THE ONCE...
Patent Expiration Date : 2025-05-21
Patent Expiration Date : 2025-05-21
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 7439393
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-2100
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-05-21
Patent Expiration Date : 2025-05-21
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 7439393
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-2100
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-05-21
Patent Expiration Date : 2029-02-26
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 11116721
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-1401
Delist Requested :
Patent Use Description : INDICATED FOR LONG-TER...
Patent Expiration Date : 2029-02-26
Patent Expiration Date : 2025-05-21
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 7439393
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-3623
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-05-21
Patent Expiration Date : 2027-06-14
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
US Patent Number : 8511304
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204275
Patent Use Code : U-3623
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-06-14
